An Exploratory Study of Cannabidiol as an Adjunctive Treatment for Refractory Epilepsy in Dogs

Kanogwan Kimram, Nirut Suwanna, Bordin Tiraphut, Sasithorn Limsuwan, Suporn Thongyuan, Natthasit Tansakul, Paul JJ Mandigers · 2025

Read An Exploratory Study of Cannabidiol as an Adjunctive Treatment for Refractory Epilepsy in Dogs by Kanogwan Kimram, Nirut Suwanna, Bordin Tiraphut, Sasithorn Limsuwan, Suporn Thongyuan, Natthasit Tansakul, Paul JJ Mandigers (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12729276.txt.

Description

Kanogwan Kimram and co-authors pilot cannabidiol oil as an add-on drug for dogs with hard-to-treat epilepsy, in a 2025 study. Standard drugs fail for many dogs, which hurts their quality of life. Thirteen dogs already taking two to six other drugs joined the trial, with dose raised slowly from a low start.

Seizure counts fell overall, with a median drop from eleven fits to five over the study window. More than six in ten dogs had at least half as many fits, and seizure clusters fell sharply. Most blood values stayed steady, though one liver enzyme rose, so liver checks matter. Owners reported better quality of life for their dogs. The authors urge tailored doses rather than one fixed dose for all.

Catalog record

CREATORKanogwan Kimram, Nirut Suwanna, Bordin Tiraphut, Sasithorn Limsuwan, Suporn Thongyuan, Natthasit Tansakul, Paul JJ Mandigers
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE41 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12729276

Browse the full library · About the Tower of Babel